 "Switzerland inks pact with Moderna for early access to firm's Covid vaccine")
Switzerland has signed an agreement with Moderna to secure early access to the Covid-19 vaccine the US biotech company is developing, the government said on Friday.
ALSO READ: Global recovery to speed up if Covid-19 vaccine available to all: WHO chief
Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million people if as expected two doses are needed per patient.
ALSO READ: AstraZeneca in deal with Kangtai Bio to supply Covid-19 vaccine in China
The government is also talking to other vaccine companies and has allocated 300 million Swiss francs ($329 million) to the project.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app